Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XHEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XHECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XHECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XHEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XHEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.168EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.168ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.168ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.168EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.168EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.168ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.57EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.57ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.57ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.57EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.57EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.6.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.6.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.6.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.238EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.238EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.238ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.238ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.238EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.238EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.238ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.238ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used